K2 Principal Fund’s Translational Development Acquisition Corp Units TDACU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-674,997
Closed -$6.76M 398
2024
Q4
$6.76M Buy
+674,997
New +$6.76M 0.75% 51

Other funds holding TDACU

K2 Principal Fund's TDACU Position: Q1 2025 in Review

K2 Principal Fund sold out of Translational Development Acquisition Corp Units (TDACU) in Q1 2025, closing a stake of 674,997 shares — an estimated $6.76M sold.

K2 Principal Fund first reported a position in TDACU in Q4 2024 and held it in 1 quarter. The position peaked at $6.76M in Q4 2024. 21 funds tracked by Wall St. Rank hold TDACU as of Q1 2025.

  • K2 Principal Fund reported no remaining Translational Development Acquisition Corp Units position as of Q1 2025 after selling out during the quarter.
  • K2 Principal Fund sold 674,997 Translational Development Acquisition Corp Units shares in Q1 2025, an estimated $6.76M.
  • K2 Principal Fund first reported a position in Translational Development Acquisition Corp Units in Q4 2024 and held it in 1 quarter.
  • K2 Principal Fund's Translational Development Acquisition Corp Units position peaked at $6.76M in Q4 2024.
  • 21 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Units as of Q1 2025.

Based on K2 Principal Fund's 13F filing for Q1 2025, filed 15 May 2025.